Levels of CD8+ PD1+ T lymphocytes in AML-ND (p < 0.0001), AML-CR (p = 0.0016) and AML-NR (p < 0.0001) were obviously elevated than those in controls (Fig. 3A, B and C). This evidence concerns the gene CD8A and acute myeloid leukemia.